UTI (UTI) CEO Jerome Grant sells 60,040 shares for tax planning

Rhea-AI Filing Summary

UNIVERSAL TECHNICAL INSTITUTE INC director and Chief Executive Officer Jerome Alan Grant reported an open-market sale of common stock. He sold 60,040 shares of common stock at a weighted average price of $34.9516 per share on February 27, 2026.

According to the disclosure, these shares were sold for the reporting person’s personal tax planning purposes. After the transaction, Grant directly owned 430,215 shares of UNIVERSAL TECHNICAL INSTITUTE INC common stock. The sale was executed through multiple trades at prices ranging from $34.41 to $35.115 per share.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Grant Jerome Alan

(Last) (First) (Middle)

4225 E. WINDROSE DRIVE, SUITE 200

(Street)

PHOENIX AZ 85032

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
UNIVERSAL TECHNICAL INSTITUTE INC [ UTI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $0.0001 par value	02/27/2026		S		60,040(1)	D	$34.9516(2)	430,215	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares were sold by the reporting person for personal tax planning purposes.

2. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $34.41 to $35.115. The reporting person undertakes to provide the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.

	/s/ Christopher Kevane, Attorney-in-Fact for Jerome Alan Grant	03/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did UTI’s CEO report on this Form 4?

UTI’s CEO Jerome Alan Grant reported selling 60,040 shares of common stock in an open-market transaction. The sale occurred on February 27, 2026, and was reported as a routine insider trade on Form 4.

At what price did the UTI CEO sell his 60,040 shares?

The CEO’s 60,040 shares were sold at a weighted average price of $34.9516 per share. Individual trades took place in multiple transactions within a price range of $34.41 to $35.115.

How many UTI shares does the CEO hold after this reported sale?

After the reported sale, UTI CEO Jerome Alan Grant directly owns 430,215 shares of UNIVERSAL TECHNICAL INSTITUTE INC common stock. This post-transaction holding reflects his remaining direct ownership following the 60,040-share open-market sale.

Why did UTI’s CEO sell shares according to the Form 4 footnotes?

The Form 4 footnotes state the shares were sold by the reporting person for personal tax planning purposes. This explanation indicates the transaction was related to individual tax considerations rather than a stated change in company outlook.

What does the price range on the UTI CEO’s Form 4 sale mean?

The filing notes the reported price is a weighted average, with trades executed between $34.41 and $35.115 per share. The insider undertakes to provide full trade breakdowns to the issuer or SEC staff upon request.

Is the UTI Form 4 transaction a buy or a sell by the CEO?

The Form 4 reports a sell transaction by the CEO. The code “S” and narrative disclosure describe an open-market sale of 60,040 common shares, classified as a sale transaction under SEC reporting rules.